The DE-CTR ACCEL Program welcomes a new Principal Investigator on July 1, 2020 !

Gregory Hicks, P.T., Ph.D., FAPTA

Professor Hicks is a clinician-scientist and a full professor in the University of Delaware Department of Physical Therapy, which ranks #1 nationally. Recently, he completed a successful five-year term as Department Chair, during which time the DPT program thrived, expanded and became more diverse. Dr. Hicks’ laboratory has had significant funding from the National Institutes of Health since 2008, including major funding for projects focused on the development and testing of interventions to improve physical function for older adults with chronic low back pain. His publication record and ongoing research demonstrates a deep understanding of the relationships between spinal disorders and functional performance in the older population, as well as his ability to conduct studies of adults with painful conditions. In addition to this primary line of work, he has been intimately involved as a collaborator in NIH-funded studies focused on understanding physical function drivers among typically aging adults and older adults post hip fracture. Professor Hicks received two B.A. degrees and a MPT degree from the University of Delaware, a Ph.D. from the University of Pittsburgh and was a postdoctoral fellow at the National Institute on Aging.

A word from Dr. Hicks:
Given the impending retirement of Dr. Stuart Binder-Macleod, the current Principal Investigator/Program Director for the Accelerating Clinical and Translational Research (DE-CTR ACCEL) Program, a search was launched to identify a suitable replacement for him. Over the years, I have worked very closely with Dr. Binder-Macleod and I share his passion for the growth of clinical and translational research within the state of Delaware. As such, I was very excited about the opportunity to apply for this position and believed that my background as an NIH-funded clinical scientist and as former chair of a nationally-ranked (#1) Physical Therapy program within the University of Delaware made me a strong candidate for this leadership role. I am thrilled to have been given the opportunity to assume the leadership of the DE-CTR ACCEL Program; and, with the assistance of Dr. Binder-Macleod, we have developed a transition plan that will allow me to be well-prepared to move into this role. My tenure as a clinician-scientist at the University of Delaware and my scientific collaborations with investigators at leading institutions nationally have given me a unique perspective and vision for the future of clinical and translational research across our partner institutions. Current leadership of the DE-CTR ACCEL Program has done an excellent job of laying a strong foundation for the growth of clinical and translational research thus far with the resources provided by NIH. As I think about the future of the CTR, I have a distinct vision focused on reducing variability in research-related processes across our partner institutions so as to efficiently create large-scale improvements in our clinical and translational research capacities; this will ultimately lead to an improvement in the health outcomes for all Delawareans. To achieve and sustain this vision, we need to establish a layered infrastructure, which includes human resources, policies, procedures and a sustainable fiscal model for this infrastructure. In the coming years, I would like to see our team focused on (1) developing much-needed research resources to support clinical and translational research growth (i.e. centers focused on recruitment, project management and data coordination); (2) developing partnership networks with established CTSAs and CTRs to advance our mission of improving health in Delaware; (3) enhancing our focus on healthcare disparities (via increased community engagement efforts and strategic efforts to diversify the research workforce); and (4) developing a stewardship model focused on sustenance and continual growth of the infrastructure and foundation that has been laid by NIH resources.

While we find ourselves in the midst of challenging times right now, I also see this as an exciting time with many opportunities for growth of the DE-CTR ACCEL Program. Given the collective strengths of our five partner institutions and the foundation that has already been laid, I am convinced that we will see more collaboration across institutions and continued growth of clinical and translational research programs that address the health needs of all Delawareans.

Gregory E. Hicks, P.T., PhD., FAPTA
Professor, Department of Physical Therapy
Associate Vice President for Clinical and Translational Research, University of Delaware
PI and Director, Delaware Clinical and Translational Research ACCEL Program

Stay Connected

Join the ACCEL newsletter and keep up to date with the latest news, events and funding opportunities!